JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank86
3Y CAGR+25.9%
5Y CAGR+18.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+25.9%/yr
vs -13.0%/yr prior
5Y CAGR
+18.0%/yr
Recent acceleration
Acceleration
+38.9pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.01 | +48.0% |
| 2024 | 1.36 | +92.5% |
| 2023 | 0.71 | -29.9% |
| 2022 | 1.01 | -61.1% |
| 2021 | 2.59 | +194.2% |
| 2020 | 0.88 | -23.3% |
| 2019 | 1.15 | -34.7% |
| 2018 | 1.76 | -17.5% |
| 2017 | 2.13 | +87.9% |
| 2016 | 1.13 | - |